Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
4.710
+0.040 (0.86%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Adaptive Biotechnologies Market Cap

Adaptive Biotechnologies has a market cap or net worth of $694.59 million as of October 29, 2024. Its market cap has increased by 12.07% in one year.

Market Cap
694.59M
Enterprise Value
628.80M
1-Year Change
12.07%
Ranking
Category
Stock Price
$4.71

Market Cap Chart

Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.88B to $694.59M, a decrease of -85.75%. That is a compound annual growth rate of -30.56%.

History

DateMarket Cap% Change
Oct 28, 2024688.70M-2.92%
Dec 29, 2023709.40M-35.07%
Dec 30, 20221.09B-72.41%
Dec 31, 20213.96B-51.03%
Dec 31, 20208.09B117.39%
Dec 31, 20193.72B-23.69%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Lexicon Pharmaceuticals 713.77M
Opthea 713.63M
Oculis Holding AG 711.76M
Tourmaline Bio 697.96M
Mineralys Therapeutics 681.26M
Humacyte 679.55M
Ironwood Pharmaceuticals 674.90M
Olema Pharmaceuticals 672.12M
Market Cap Rankings